Bronchoalveolar Cell Lung Cancer Terminated Phase 1 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028477 (Bronchoalveolar Cell Lung Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00042835Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung CancerTreatment